Skip to main content
Livermore
Livermore
ZHEN

Citadel Advisors LLC

SEC CIK
0001423053
Latest filing
Sep 1, 2026

BEAM holding history

Beam Therapeutics Inc. in every 13F filed by Citadel Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BEAM overviewAll 13F holders of BEAMFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
20
Since Q1 2021
Holdings of BEAM by Citadel Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−528,970−100.0%Sold outHolders
Q1 2026528,970$12.6M<0.1%+273,260+106.9%AddedHolders
Q4 2025255,710$7.09M<0.1%+255,710NewHolders
Q3 20250$00.0%−2,337,517−100.0%Sold outHolders
Q2 20252,337,517$39.8M<0.1%−162,830−6.5%ReducedHolders
Q1 20252,500,347$48.8M<0.1%+438,101+21.2%AddedHolders
Q4 20242,062,246$51.1M<0.1%+566,051+37.8%AddedHolders
Q3 20241,496,195$36.7M<0.1%+727,041+94.5%AddedHolders
Q2 2024769,154$18.0M<0.1%+729,641+1,846.6%AddedHolders
Q1 202439,513$1.31M<0.1%+28,068+245.2%AddedHolders
Q4 202311,445$311.5K<0.1%−1,165,470−99.0%ReducedHolders
Q3 20231,176,915$28.3M<0.1%+857,371+268.3%AddedHolders
Q2 2023319,544$10.2M<0.1%+138,344+76.3%AddedHolders
Q1 2023181,200$5.55M<0.1%+51,938+40.2%AddedHolders
Q4 2022129,262$5.06M<0.1%+34,930+37.0%AddedHolders
Q3 202294,332$4.49M<0.1%+41,000+76.9%AddedHolders
Q2 202253,332$2.06M<0.1%−111,186−67.6%ReducedHolders
Q1 2022164,518$9.43M<0.1%+83,789+103.8%AddedHolders
Q4 202180,729$6.43M<0.1%−135,463−62.7%ReducedHolders
Q3 2021216,192$18.8M<0.1%+194,580+900.3%AddedHolders
Q2 202121,612$2.78M<0.1%−135,705−86.3%ReducedHolders
Q1 2021157,317$12.6M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.